Sign in

You're signed outSign in or to get full access.

Jill R. Goodman

Director at Cboe Global MarketsCboe Global Markets
Board

About Jill R. Goodman

Independent director of Cboe Global Markets since 2012; age 58. Managing Director at Foros (strategic financial and M&A advisory) since November 2013; previously Managing Director and Head, Special Committee & Fiduciary Practice—U.S. at Rothschild (2010–Oct 2013) and Managing Director in Lazard’s M&A and Strategic Advisory Group (1998–2010). Education: B.A. magna cum laude, Rice University; J.D. with honors, University of Chicago Law School .

Past Roles

OrganizationRoleTenureCommittees/Impact
ForosManaging DirectorNov 2013–present Advises companies and special committees on M&A
RothschildManaging Director; Head, Special Committee & Fiduciary Practice—U.S.2010–Oct 2013 Special committee advisory leadership
LazardManaging Director (M&A and Strategic Advisory Group)1998–2010 M&A and strategic advisory experience

External Roles

OrganizationRolePublic/PrivateTenureCommittees/Notes
Genworth Financial, Inc.DirectorPublicCurrent Corporate governance experience
Cover GeniusDirectorPrivate (global insurtech)Current Technology/insurtech exposure

Board Governance

  • Independence: Independent director .
  • Tenure on Cboe Board: Since 2012 .
  • Committee assignments: Executive (member), Finance and Strategy (Chair), Nominating and Governance (member) .
  • Special Committee engagement: Member of ad hoc Special Committee formed Aug 2023 regarding investigation of personal relationships; met twice in 2024 .
  • Attendance: Board met 9 times in 2024; each director attended at least 75% of Board and committee meetings; all current directors attended the 2024 Annual Meeting; independent directors met in executive session 6 times in 2024 .
Governance ItemDetail
IndependenceIndependent
Board Service Since2012
2024 Board Meetings9
Attendance Threshold≥75% for all directors in 2024
Annual Meeting Attendance (2024)All current directors attended
Executive Sessions (Independent Directors)6 in 2024
CommitteesExecutive (member); Finance & Strategy (Chair); Nominating & Governance (member)
2024 Committee Meeting CountsFinance & Strategy: 6; Nominating & Governance: 7; Executive: not listed (—)

Fixed Compensation

  • Director pay philosophy: Near median of peer group; reviewed by independent consultant Meridian Compensation Partners; mix of cash/equity retainers, committee retainers, and meeting fees; Risk Committee member retainer increased in 2024 due to responsibilities .
  • Annual fee structure (May 2024–May 2025): Cash retainer $90,000; stock retainer $170,000; Finance & Strategy Chair retainer $15,000; Nominating & Governance member retainer $12,000; meeting attendance fee $1,500 per meeting above baseline +2 (committee-specific baselines) .
2024 Director Compensation (Paid/Granted)Amount
Fees Earned or Paid in Cash (Goodman)$129,000
Stock Awards (Grant-Date Fair Value)$170,159
All Other Compensation$0
Total$299,159
Program Component (May 2024–May 2025)Base Amount
Cash Retainer$90,000
Stock Retainer (value at grant close)$170,000
Finance & Strategy Chair Cash Retainer$15,000
Nominating & Governance Member Cash Retainer$12,000
Committee Meeting Attendance Fee (per meeting beyond baseline +2)$1,500

Performance Compensation

  • Director equity awards are time-based RSUs (no performance metrics). RSUs vest on the earlier of the one-year anniversary of grant or completion of final year of director service, subject to continuous service. Non-employee directors then-serving received RSUs on May 16, 2024; each listed director held 937 unvested RSUs as of December 31, 2024 (Mansfield/Mao held 1,182 due to pro-rata grants) .
Director Equity Award Details (Goodman)Value
Grant DateMay 16, 2024
Award TypeRSUs
Shares Unvested at 12/31/2024937
Grant-Date Fair Value$170,159
Vesting ScheduleEarlier of 1-year from grant or completion of final director year; continuous service required
Deferral Election (2024)Elected to defer 100% of 2024 equity grant under Director Equity Deferral Plan
  • Deferral mechanics: Deferred RSUs credited as notional stock units until distribution in shares upon elected distribution date; dividend equivalents accrue; amounts paid in shares as single lump sum at distribution; no matching contributions; equity subject to vesting requirements .

Other Directorships & Interlocks

CompanyRelationship to Cboe/Interlock Risk
Genworth Financial, Inc.No related-party transactions involving Ms. Goodman disclosed; compensation committee interlocks: none for committee members; no interlocks noted for Goodman .
Cover GeniusNo related-party transactions involving Ms. Goodman disclosed .
  • Related-party review: Audit Committee oversees and approves related-party transactions; except as disclosed (e.g., Ratterman family employment; index provider/license ties; banking relationships with Goldman/Barclays), no transactions >$120,000 since Jan 1, 2024; none involve Ms. Goodman .

Expertise & Qualifications

  • Strategic M&A advisory and special committee expertise from Foros/Rothschild/Lazard; corporate/securities legal background (J.D., UChicago Law) .
  • Board qualifications include corporate governance experience through other company board service .
  • Education credentials: B.A. magna cum laude (Rice); J.D. with honors (UChicago Law) .

Equity Ownership

  • Stock ownership guidelines: 5x cash annual retainer within 5 years; directors must hold all shares from annual equity awards until guidelines met; as of Dec 31, 2024, all incumbent directors (other than 2024 new appointees) met the requirement .
  • Hedging/pledging: Prohibited; in 2024 none of the directors had hedges, pledges, or margin loans on Cboe stock .
Ownership Item (as of Mar 18, 2025)Detail
Beneficial Shares Owned (Goodman)11,189
Percent of Outstanding<1%
RSUs Vesting Within 60 Days Included937
Hedging/Pledging StatusNone; prohibited by policy
Ownership Guideline ComplianceMet as of Dec 31, 2024 (incumbent directors)

Insider Trades

DateFormTransactionSharesApprox. ValueSource
Mar 12, 2025Form 4 filed Mar 14, 2025Sale2,684$560,592

Compensation Committee Analysis (Context)

  • Composition (2024): Fitzpatrick (Chair), Froetscher, Parisi; all independent; no compensation committee interlocks with other entities; Meridian retained as independent consultant .
  • Annual award limits: Non-employee director total compensation (cash plus equity grant-date fair value) capped at $950,000 per calendar year under the Long-Term Incentive Plan .

Say-on-Pay & Shareholder Feedback

  • 2025 Annual Meeting: All 12 director nominees (including Goodman) received majority of votes cast; shareholders approved advisory say-on-pay; KPMG ratified as auditor; plan amendments approved; final vote totals to be reported in Form 8‑K .
  • Ongoing investor engagement: Company engaged with holders of ~47% of common stock in 2024 on governance/executive pay; targeted outreach to top holders representing ~40% outstanding .

Governance Assessment

  • Strengths:
    • Independent director with deep M&A and special committee expertise; chairs Finance & Strategy and serves on Nominating & Governance—positions central to capital allocation and board composition .
    • Documented engagement: participation in 2023–2024 Special Committee; independent directors held 6 executive sessions in 2024; attendance at least 75%; all directors attended 2024 Annual Meeting .
    • Alignment: met stock ownership guidelines; 11,189 beneficial shares including near-term vesting RSUs; hedging/pledging prohibited and none in 2024; elected to defer 100% of 2024 equity grant, increasing long-term exposure to Cboe stock .
    • Compensation structure appropriate for independence (cash retainer + time-based RSUs; reasonable committee retainers) and within plan annual limits .
  • Potential Red Flags:
    • None disclosed specific to Ms. Goodman: no related-party transactions involving her; no hedging/pledging; attendance met policy thresholds .
    • Note: Insider sale in March 2025 appears modest relative to holdings; continue monitoring Form 4 activity for pattern changes .

Implications: Goodman’s chair role on Finance & Strategy aligns with her M&A background and positions her as an influential voice on capital allocation. Deferral of equity awards and compliance with ownership guidelines support skin-in-the-game. Absence of conflicts and strong attendance bolster investor confidence .